Doosup Shin1, Kullatham Kongpakpaisarn2, Chandrashekar Bohra2. 1. Department of Internal Medicine, University of South Florida Morsani College of Medicine, Tampa, FL, United States. Electronic address: dshin@health.usf.edu. 2. Department of Internal Medicine, University of South Florida Morsani College of Medicine, Tampa, FL, United States.
Abstract
BACKGROUND: Recent trends in the prevalence of metabolic syndrome (MetS) and its components among U.S. adults are not known. METHODS: We performed an updated analysis using the National Health and Nutrition Examination Survey 2007-2014 data to investigate the latest trends of prevalence of MetS and its components. MetS was defined based on the modified National Cholesterol Education Program-Adult Treatment Panel III criteria. Multiple regression models were used to assess linear trends over the years, after adjusting for sex, age, and race/ethnicity, as appropriate. Sampling weights were considered to account for complex sampling design, and all estimates were adjusted by age by a direct method. RESULTS: During 2007-2014, the age-adjusted weighted prevalence (±standard error) of MetS among U.S. adults was 34.3 ± 0.8%. In age-stratified analysis, 54.9 ± 1.7% of elderly population aged 60 and over had MetS. When evaluating trends from 2007 to 2014, the prevalence of MetS remained stable in all sex, age, and race/ethnicity groups (P-trends > 0.100 for all). Among the components of MetS, the prevalence of hypertriglyceridemia and fasting hyperglycemia decreased (P-trend <0.050). However, the prevalence of abdominal obesity significantly increased, especially in women (P-trend = 0.009). The prevalence of elevated blood pressure and low high-density lipoprotein cholesterol level remained stable. CONCLUSIONS: The prevalence of MetS remained stable during 2007-2014. However, it was still prevalent in the U.S., especially among the elderly population. The prevalence of abdominal obesity continued to increase in women for which more efforts should be made.
BACKGROUND: Recent trends in the prevalence of metabolic syndrome (MetS) and its components among U.S. adults are not known. METHODS: We performed an updated analysis using the National Health and Nutrition Examination Survey 2007-2014 data to investigate the latest trends of prevalence of MetS and its components. MetS was defined based on the modified National Cholesterol Education Program-Adult Treatment Panel III criteria. Multiple regression models were used to assess linear trends over the years, after adjusting for sex, age, and race/ethnicity, as appropriate. Sampling weights were considered to account for complex sampling design, and all estimates were adjusted by age by a direct method. RESULTS: During 2007-2014, the age-adjusted weighted prevalence (±standard error) of MetS among U.S. adults was 34.3 ± 0.8%. In age-stratified analysis, 54.9 ± 1.7% of elderly population aged 60 and over had MetS. When evaluating trends from 2007 to 2014, the prevalence of MetS remained stable in all sex, age, and race/ethnicity groups (P-trends > 0.100 for all). Among the components of MetS, the prevalence of hypertriglyceridemia and fasting hyperglycemia decreased (P-trend <0.050). However, the prevalence of abdominal obesity significantly increased, especially in women (P-trend = 0.009). The prevalence of elevated blood pressure and low high-density lipoprotein cholesterol level remained stable. CONCLUSIONS: The prevalence of MetS remained stable during 2007-2014. However, it was still prevalent in the U.S., especially among the elderly population. The prevalence of abdominal obesity continued to increase in women for which more efforts should be made.
Authors: Diana A Chirinos; Maria M Llabre; Ronald Goldberg; Marc Gellman; Armando Mendez; Jianwen Cai; Daniela Sotres-Alvarez; Marta Daviglus; Linda C Gallo; Neil Schneiderman Journal: Diabetes Care Date: 2020-06-19 Impact factor: 19.112
Authors: A B Moraes; E M R Cavalari; M P de Paula; M Arruda; D S C Curi; R A Leitão; L M C de Mendonça; M L F Farias; M Madeira; L Vieira Neto Journal: J Endocrinol Invest Date: 2018-11-21 Impact factor: 4.256
Authors: Erica C Jansen; Galit Levi Dunietz; Maria-Efstratia Tsimpanouli; Heidi M Guyer; Carol Shannon; Shelley D Hershner; Louise M O'Brien; Ana Baylin Journal: Curr Nutr Rep Date: 2018-12
Authors: Anda Botoseneanu; Haiying Chen; Walter T Ambrosius; Heather G Allore; Stephen Anton; Sara C Folta; Abby C King; Barbara J Nicklas; Bonnie Spring; Elsa S Strotmeyer; Thomas M Gill Journal: Exp Gerontol Date: 2021-04-10 Impact factor: 4.032
Authors: Grzegorz Józef Nowicki; Barbara Ślusarska; Katarzyna Naylor; Andrzej Prystupa; Ewa Rudnicka-Drożak; Ulyana Halyuk; Petro Pokotylo Journal: Diabetes Metab Syndr Obes Date: 2021-05-06 Impact factor: 3.168
Authors: Barnaly Rashid; Victoria N Poole; Francesca C Fortenbaugh; Michael Esterman; William P Milberg; Regina E McGlinchey; David H Salat; Elizabeth C Leritz Journal: Neurobiol Aging Date: 2021-04-01 Impact factor: 5.133